The existence of pulmonary disease attributable to Bacillus Friedländeri has been recognized for a number of years. Most of the previous reports have been based on isolated cases or small groups of cases, with two or three outbreaks approaching epidemic proportions. Examination of these reports reveals that they have been concerned with various features of the organism and the disease.
There have been extensive bacteriologic, cultural and immunologic studies of Friedländeri, with more recent work on their subdivision into several morphologically identical but serologically distinct groups. These have been further concerned with the etiologic significance of the presence of B. Friedländeri in diseased pulmonary tissue and its relative incidence in the pneumonias, in extrapulmonary diseases and in the carrier state.
Clinical study has distinguished the chronic form of the disease, which simulates pulmonary tuberculosis, from the acute fulminating form, with a uniformly high mortality rate, like that of pneumococcic lobar
BULLOWA JGM, CHESS J, FRIEDMAN NB. PNEUMONIA DUE TO BACILLUS FRIEDLÄNDERI: A REPORT ON FORTY-ONE PATIENTS, WITH CONSIDERATION OF SPECIFIC SERUM THERAPY. Arch Intern Med (Chic). 1937;60(5):735–752. doi:10.1001/archinte.1937.00180050002001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: